Bumper Offer - Urjas oil Just @ Rs. 1
Nebicard 2.5 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP.
Medical history of the patient along with age and gender determines the dosage of Nebicard 2.5 Tablet. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Nebicard 2.5 Tablet as well, which are listed below. Usually, these side effects of Nebicard 2.5 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Nebicard 2.5 Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. Further, the section on Nebicard 2.5 Tablet related warnings talks about Nebicard 2.5 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) must refrain from the use of Nebicard 2.5 Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Nebicard 2.5 Tablet are listed in the contraindications section below.
Drug reaction of Nebicard 2.5 Tablet with other medicines has been reported. See below for a complete list.
You should also be aware that Nebicard 2.5 Tablet is not safe while driving, and is not addiction.
Nebicard 2.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Nebicard 2.5 Tablet is used -
Severe
Moderate
Mild
Is the use of Nebicard 2.5 Tablet safe for pregnant women?
Nebicard shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebicard 2.5 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebicard. It should only be taken after medical advice.
What is the effect of Nebicard 2.5 Tablet on the Kidneys?
Nebicard has very mild side effects on the kidneys.
What is the effect of Nebicard 2.5 Tablet on the Liver?
Nebicard may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebicard 2.5 Tablet on the Heart?
Side effects of Nebicard rarely affect the heart.
Nebicard 2.5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Nebicard 2.5 Tablet unless your doctor advises you to do so -
Is this Nebicard 2.5 Tablet habit forming or addictive?
Nebicard 2.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Nebicard 2.5 Tablet can make you feel drowsy.
Is it safe?
Yes, Nebicard 2.5 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Nebicard 2.5 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Nebicard 2.5 Tablet
Eating certain foods may increase the time it takes Nebicard 2.5 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebicard 2.5 Tablet
Consumption of alcohol and Nebicard 2.5 Tablet together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
